Works about GLIOBLASTOMA multiforme treatment


Results: 1182
    1
    2
    3
    4
    5

    Down-regulation of MDR1 by Ad-DKK3 via Akt/NFκB pathways augments the anti-tumor effect of temozolomide in glioblastoma cells and a murine xenograft model.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 139, n. 2, p. 323, doi. 10.1007/s11060-018-2894-5
    By:
    • Fujihara, Toshitaka;
    • Mizobuchi, Yoshifumi;
    • Nakajima, Kohei;
    • Kageji, Teruyoshi;
    • Matsuzaki, Kazuhito;
    • Kitazato, Keiko T.;
    • Otsuka, Ryotaro;
    • Hara, Keijiro;
    • Mure, Hideo;
    • Okazaki, Toshiyuki;
    • Kuwayama, Kazuyuki;
    • Nagahiro, Shinji;
    • Takagi, Yasushi
    Publication type:
    Article
    6
    7
    8

    Management of glioblastoma at safety-net hospitals.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 139, n. 2, p. 389, doi. 10.1007/s11060-018-2875-8
    By:
    • Brandel, Michael G.;
    • Rennert, Robert C.;
    • Lopez Ramos, Christian;
    • Santiago-Dieppa, David R.;
    • Steinberg, Jeffrey A.;
    • Sarkar, Reith R.;
    • Wali, Arvin R.;
    • Pannell, J. Scott;
    • Murphy, James D.;
    • Khalessi, Alexander A.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15

    JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 138, n. 3, p. 627, doi. 10.1007/s11060-018-2831-7
    By:
    • Wakabayashi, Toshihiko;
    • Natsume, Atsushi;
    • Mizusawa, Junki;
    • Katayama, Hiroshi;
    • Fukuda, Haruhiko;
    • Sumi, Minako;
    • Nishikawa, Ryo;
    • Narita, Yoshitaka;
    • Muragaki, Yoshihiro;
    • Maruyama, Takashi;
    • Ito, Tamio;
    • Beppu, Takaaki;
    • Nakamura, Hideo;
    • Kayama, Takamasa;
    • Sato, Shinya;
    • Nagane, Motoo;
    • Mishima, Kazuhiko;
    • Nakasu, Yoko;
    • Kurisu, Kaoru;
    • Yamasaki, Fumiyuki
    Publication type:
    Article
    16
    17
    18

    ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 138, n. 3, p. 479, doi. 10.1007/s11060-018-2819-3
    By:
    • Dréan, Antonin;
    • Rosenberg, Shai;
    • Lejeune, François-Xavier;
    • Goli, Larissa;
    • Nadaradjane, Aravindan Arun;
    • Guehennec, Jérémy;
    • Schmitt, Charlotte;
    • Verreault, Maïté;
    • Bielle, Franck;
    • Mokhtari, Karima;
    • Sanson, Marc;
    • Carpentier, Alexandre;
    • Delattre, Jean-Yves;
    • Idbaih, Ahmed
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Is a pretreatment radiological staging system feasible for suggesting the optimal extent of resection and predicting prognosis in glioblastoma? An observational study.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 137, n. 2, p. 367, doi. 10.1007/s11060-017-2726-z
    By:
    • Capellades, Jaume;
    • Puig, Josep;
    • Domenech, Sira;
    • Pujol, Teresa;
    • Oleaga, Laura;
    • Camins, Angels;
    • Majós, Carles;
    • Diaz, Rocio;
    • de Quintana, Christian;
    • Teixidor, Pilar;
    • Conesa, Gerard;
    • Plans, Gerard;
    • Gonzalez, Josep;
    • García-Balañà, Natalia;
    • Velarde, Jose Maria;
    • Balaña, Carmen
    Publication type:
    Article
    33

    Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 136, n. 2, p. 273, doi. 10.1007/s11060-017-2649-8
    By:
    • Sage, William;
    • Guilfoyle, Mathew;
    • Luney, Catriona;
    • Young, Adam;
    • Sinha, Rohitashwa;
    • Sgubin, Donatella;
    • McAbee, Joseph H.;
    • Ma, Ruichong;
    • Jefferies, Sarah;
    • Jena, Rajesh;
    • Harris, Fiona;
    • Allinson, Kieren;
    • Matys, Tomasz;
    • Qian, Wendi;
    • Santarius, Thomas;
    • Price, Stephen;
    • Watts, Colin
    Publication type:
    Article
    34
    35

    Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 136, n. 2, p. 363, doi. 10.1007/s11060-017-2660-0
    By:
    • Cardona, Andrés F.;
    • Rojas, Leonardo;
    • Wills, Beatriz;
    • Bernal, Laura;
    • Ruiz-Patiño, Alejandro;
    • Arrieta, Oscar;
    • Hakim, Enrique Jiménez;
    • Hakim, Fernando;
    • Mejía, Juan Armando;
    • Useche, Nicolás;
    • Bermúdez, Sonia;
    • Carranza, Hernán;
    • Vargas, Carlos;
    • Otero, Jorge;
    • Mayor, Luis Carlos;
    • Ortíz, León Darío;
    • Franco, Sandra;
    • Ortíz, Carlos;
    • Gil-Gil, Miguel;
    • Balaña, Carmen
    Publication type:
    Article
    36
    37
    38

    Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 136, n. 1, p. 79, doi. 10.1007/s11060-017-2624-4
    By:
    • Nghiemphu, Phioanh Leia;
    • Ebiana, Victoria Asuquo;
    • Wen, Patrick;
    • Gilbert, Mark;
    • Abrey, Lauren E.;
    • Lieberman, F.;
    • DeAngelis, Lisa M.;
    • Robins, H. Ian;
    • Yung, W. K. Alfred;
    • Chang, Susan;
    • Drappatz, Jan;
    • Mehta, Minesh P.;
    • Levin, Victor A.;
    • Aldape, Kenneth;
    • Dancey, Janet E.;
    • Wright, J. J.;
    • Prados, Michael;
    • Kuhn, John;
    • Cloughesy, Timothy F.
    Publication type:
    Article
    39
    40
    41

    Long-term survivors of glioblastoma: a closer look.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 136, n. 1, p. 155, doi. 10.1007/s11060-017-2635-1
    By:
    • Gately, Lucy;
    • McLachlan, Sue-Anne;
    • Philip, Jennifer;
    • Ruben, Jeremy;
    • Dowling, Anthony
    Publication type:
    Article
    42
    44
    45
    46
    47

    Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2017, v. 135, n. 3, p. 545, doi. 10.1007/s11060-017-2601-y
    By:
    • Zhu, Jay-Jiguang;
    • Demireva, Petya;
    • Kanner, Andrew;
    • Pannullo, Susan;
    • Mehdorn, Maximilian;
    • Avgeropoulos, Nicholas;
    • Salmaggi, Andrea;
    • Silvani, Antonio;
    • Goldlust, Samuel;
    • David, Carlos;
    • Benouaich-Amiel, Alexandra
    Publication type:
    Article
    48
    49

    Current trends in mouse models of glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2017, v. 135, n. 3, p. 423, doi. 10.1007/s11060-017-2626-2
    By:
    • Miyai, Masafumi;
    • Tomita, Hiroyuki;
    • Soeda, Akio;
    • Yano, Hirohito;
    • Iwama, Toru;
    • Hara, Akira
    Publication type:
    Article
    50

    Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?

    Published in:
    Journal of Neuro-Oncology, 2017, v. 135, n. 2, p. 285, doi. 10.1007/s11060-017-2573-y
    By:
    • Zanello, Marc;
    • Roux, Alexandre;
    • Ursu, Renata;
    • Peeters, Sophie;
    • Bauchet, Luc;
    • Noel, Georges;
    • Guyotat, Jacques;
    • Le Reste, Pierre-Jean;
    • Faillot, Thierry;
    • Litre, Fabien;
    • Desse, Nicolas;
    • Emery, Evelyne;
    • Petit, Antoine;
    • Peltier, Johann;
    • Voirin, Jimmy;
    • Caire, François;
    • Barat, Jean-Luc;
    • Vignes, Jean-Rodolphe;
    • Menei, Philippe;
    • Langlois, Olivier
    Publication type:
    Article